Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness
Open Access
- 16 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1057484
Abstract
Ovarian cancer is known to be the most lethal malignancy among all gynecological cancers affecting a large number of women worldwide. The treatment of ovarian cancer is challenging due to the high recurrence rate of the disease and is further complicated by acquired chemoresistance. Most ovarian cancer deaths are the result of the metastatic spread of drug-resistant cells. The theory of cancer stem cells (CSC) suggests that both tumor initiation and progression are driven by a population of undifferentiated capable of self-renewal, tumor initiation and development of chemoresistance. The CD117 mast/stem cell growth factor receptor (KIT) is the most commonly used marker for ovarian CSCs. Here, we analyze the correlation between CD117 expression and histological tumor type in ovarian cancer cell lines (SK-OV-3 and MES-OV) and in small/medium extracellular vesicles (EVs) isolated from the urine of ovarian cancer patients. We have demonstrated that the abundance of CD117 on cells and EVs is correlated with tumor grade and therapy resistance status. Moreover, using small EVs isolated from ovarian cancer ascites, it was shown that recurrent disease is characterized by a much higher abundance of CD117 on EVs than primary tumor.Keywords
This publication has 35 references indexed in Scilit:
- Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancerOncotarget, 2016
- Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocolScientific Reports, 2015
- Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapyJournal of Obstetrics and Gynaecology Research, 2015
- Proteome–Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular CommunicationMolecular & Cellular Proteomics, 2014
- Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachJournal of Experimental & Clinical Cancer Research, 2013
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational ResearchFrontiers in Oncology, 2013
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signalingOncogene, 2012
- Upregulation of CD9 in ovarian cancer is related to the induction of TNF-α gene expression and constitutive NF-κB activationCarcinogenesis, 2011
- On the abundance of EpCAM on cancer stem cellsNature Reviews Cancer, 2009
- A primary retroperitoneal serous cystadenocarcinoma with clinically aggressive behaviorArchives of Gynecology and Obstetrics, 2003